Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH2 | P05091 | 5/20 | 0.44 |
| ▸ | ALDH1A2 | O94788 | 4/20 | 0.44 |
| ▸ | ALDH1B1 | P30837 | 4/20 | 0.44 |
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12019531 | 0.77 | KDM4E (0.45) | ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E | |
| SCHEMBL278526 | 0.73 | — | — | |
| SCHEMBL11859981 | 0.73 | ALDH2 (0.32) | ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E | |
| SCHEMBL11996096 | 0.72 | ALDH2 (0.31) | ALDH2ALDH1A2ALDH1B1ALDH1A3 | |
| SCHEMBL1400093 | 0.71 | LIPE (0.31) | ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E | |
| Hydrogen Sulfide SCHEMBL23148272 | 0.70 | POLB (0.33) | — | |
| SCHEMBL13431325 | 0.69 | ALDH1A1 (0.39) | ALDH2ALDH1A2ALDH1B1ALDH1A3ALDH1A1 | |
| SCHEMBL12558040 | 0.67 | KDM4E (0.40) | ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E | |
| SCHEMBL905101 | 0.67 | — | — | |
| SCHEMBL15142248 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107484766-A | Agricultural chemicals and preparation, application process based on natural cumarin essential oil in common fig leaf juice | 郑州市汇川农业科技有限公司 | 2017-12-19 | — | — | CN | claimed |
| CN-107484766-A | Agricultural chemicals and preparation, application process based on natural cumarin essential oil in common fig leaf juice | 郑州市汇川农业科技有限公司 | 2017-12-19 | — | — | CN | disclosed |
| US-8907089-B2 | Fused heterocyclic ring derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-12-09 | — | — | US | disclosed |
| US-20120220570-A1 | FUSED HETEROCYCLIC RING DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-08-30 | — | — | US | disclosed |
| CN-1153784-C | Metallocene compound, its preparation method and its application in polymerization of olefine | 北京燕山石油化工公司研究院 | 2004-06-16 | — | — | CN | disclosed |
| CN-1263110-A | Metallocene compound, its preparation method and its application in polymerization of olefine | RES INST BEIJING YANSHAN PETRO (CN) | 2000-08-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120220570-A1 | FUSED HETEROCYCLIC RING DERIVATIVE AND USE THEREOF | SMO, GLI1, SHH | ALDH2 978/4885ALDH1A2 230/4885ALDH1B1 353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.